Technology: TyRx is dedicated to designing, developing, and commercializing next-generation resorbable polymeric biomaterials. The Company’s first series of tyrosine-based resorbable polymer systems have been created for use in drug delivery and medical device applications.

The Company’s core technology enables the rapid and intelligent selection of polymers, on an application-by-application basis, from that covers a broad range of desirable properties for multiple medical indications with characteristics superior to existing biomaterials relative to breadth of deliverable molecules additional to improved biocompatibility.

The Company’s approach to materials design is based on the systematic generation and characterization of libraries of materials created using the techniques of combinatorial chemistry.

Intellectual Property: TyRx holds an exclusive worldwide license from Rutgers, the State University of New Jersey, to a comprehensive patent portfolio and patent applications covering tyrosine-based resorbable polymer systems: the structures, synthesis and molding of the polyarylate library; synthesis and molding of radio-opaque polyarylates; and new polymer libraries synthesized in a combinatorial manner for both medical and non-medical applications. The Company’s intellectual property strategy is to file for protection in major world markets, including the United States, Europe, Japan, Canada, and Australia. To date, thirteen U.S. patents or patent applications have been licensed to the Company by Rutgers University.